Posts
Showing posts with the label Immunotherapy
The New Dawn in Bladder Cancer: EV-302 and the End of the "Chemo-Only" Era
- Get link
- X
- Other Apps
EV-302: The Trial That Revolutionized First-Line Bladder Cancer Treatment
- Get link
- X
- Other Apps
Practice Changing Article review : CheckMate 649 - Five-Year Survival Data Redefines the Standard of Care for Advanced Gastric Cancer
- Get link
- X
- Other Apps
Top 10 things in Immuno-oncology to take away from 2025
- Get link
- X
- Other Apps
Clinical Guide for Management of MMM (Myositis-Myocarditis-Myasthenia Gravis) Overlap Syndrome Evidence-Based Guide for Healthcare Professionals
- Get link
- X
- Other Apps
Article review: Long term results of Keynote 412- supports lack of clear benefit by immunotherapy to CRT in H&N cancers
- Get link
- X
- Other Apps
High Impact Article review : Durvalumab in MIBC , NIAGARA study
- Get link
- X
- Other Apps
Immunotherapy Toxicity : Summary guide for ready reference
- Get link
- X
- Other Apps
Weekly Journal Scan : Focus on Immunotherapy this week
- Get link
- X
- Other Apps